Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term randomized double-blind trial of SD-6010 in obese women with knee osteoarthritis
2007-001457-26Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cindunistat in knee osteoarthritis (OA) and osteoarthritis (OA) (3 arms), sponsored by Pfizer. Primary endpoint: Radiographic progression rate of joint space narrowing in the medial tibiofemoral compartment. Started Oct 2007; status: completed.
02
Drugs
cindunistat
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on 2007-001457-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001457-26.